
pmid: 2385099
AbstractPrimary adenocarcinoma of the appendix is rare. Eleven patients with this rare neoplasm have been evaluated at our institution over a 50‐year period. We have reviewed the presentation and clinical course of these patients, and have compared them with those described in the literature. The presenting signs and symptoms, physical findings, and treatment were similar to those described in the literature. However, the 5‐year survival of 20% is lower than most series, and reflects the advanced stage of disease at the time of diagnosis in this group of patients. Despite the low 5‐year survival, we feel that aggressive therapy (right hemicolectomy) is necessary to obtain long‐term survival.
Adult, Male, Adenocarcinoma, Middle Aged, Combined Modality Therapy, Survival Rate, Appendiceal Neoplasms, Humans, Female, Aged, Neoplasm Staging
Adult, Male, Adenocarcinoma, Middle Aged, Combined Modality Therapy, Survival Rate, Appendiceal Neoplasms, Humans, Female, Aged, Neoplasm Staging
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
